期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 ()
BACKGROUND: The General Medical Council (GMC) states that all intimate examinations should have a chaperone offered. Documentation of chaperone identi......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 ()
BACKGROUND: Since the outbreak of the coronavirus (SARS-Cov-2), wearing personal protective equipment (PPE) has become necessary. Patients' ability to......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 (3)
BACKGROUND: Hepatitis B virus (HBV) infection is a serious global public health problem, with significant morbidity and mortality from acute and chron......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 (2)
BACKGROUND: Point 7 of the Rome Declaration is aimed at improving data sharing and technological and knowledge transfer as instruments to implement he......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 (1)
BACKGROUND: Pheniramine abuse is reported not only in patients with psychiatric disorders but also in the general population. CASE REPORT: We report a......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 ()
BACKGROUND: With the majority of antibiotics being prescribed in primary care it is of utmost importance that antimicrobial stewardship principles are......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 ()
BACKGROUND: Previous reports have shown that there are long waiting times to commence therapy in the community-based mental health programme, IAPT (Im......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 (3)
BACKGROUND: The COVID-19 pandemic has shocked society worldwide. Multiple efforts went immediately into developing treatments for managing and vaccine......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 ()
BACKGROUND: Patients in psychiatric inpatient settings are at increased risk of developing physical health complications due to the structure of inpat......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 (4)
BACKGROUND: Fluoxetine was approved for depression in children and adolescents based on two placebo-controlled trials, X065 and HCJE, with 96 and 219 ......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 (4)
BACKGROUND: The patients' guide by the Batz Patient Safety Foundation promotes patients' active participation in healthcare and a safe hospital experi......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 (1)
BACKGROUND: Individuals with diabetes mellitus (DM) may be susceptible to non-steroidal anti-inflammatory drug (NSAID)-induced acute kidney injury (AK......
期刊： INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2022; 33 (1)
BACKGROUND: The majority of antidepressants inhibit serotonin reuptake and include the selective serotonin reuptake inhibitors (SSRIs), serotonin-nore......
